Suchergebnisse - "Shiu, Kai-Keen"

PubPharm (3)

1

Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177) : final analysis of a randomised, open-label, phase 3 study

enthalten in: The Lancet. Oncology | 2022

von Diaz, L. | Shiu, K. | Kim, T. | +17

CommentIn: Lancet Oncol. 2022 Jun;23(6):e245. - PMID 35654062

2

Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer

enthalten in: The New England journal of medicine | 2020

von André, T. | Shiu, K. | Kim, T. | +119

CommentIn: N Engl J Med. 2020 Dec 3;383(23):2283-2285. - PMID 33264550

3

Review of metastatic colorectal cancer treatment pathways and early clinical experience of trifluridine/tipiracil in the UK named patient programme

enthalten in: BMC cancer | 2020

von Iveson, T. | Carter, A. | Shiu, K. | +3

1
[1]